Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation-Reply.
Department of Neurology, University of California, San Francisco.
Stacy Ellen
SE
Hatcher
Department of Neurology, University of California, San Francisco.
Emmanuelle
E
Waubant
Department of Neurology, University of California, San Francisco.
Jennifer S
JS
Graves
D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents; D009103:Multiple Sclerosis; D020529:Multiple Sclerosis, Relapsing-Remitting
D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride